Fingerprint
Dive into the research topics of 'Adding Ovarian Suppression to Tamoxifen for Premenopausal Women with Hormone Receptor-Positive Breast Cancer after Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically